Immucell Corp (ICCC) USD0.10

Sell:$4.59Buy:$5.31$0.05 (1.00%)

Prices delayed by at least 15 minutes
Sell:$4.59
Buy:$5.31
Change:$0.05 (1.00%)
Prices delayed by at least 15 minutes
Sell:$4.59
Buy:$5.31
Change:$0.05 (1.00%)
Prices delayed by at least 15 minutes

Company Information

About this company

ImmuCell Corporation is an animal health company. The Company is engaged in the development, acquisition, manufacture, and sale of products that improve the health and productivity of dairy and beef cattle. It operates in two business segments: Scours and Mastitis. The Scours segment is engaged in manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows. The First Defense product line provides bovine antibodies that newborn calves need but are unable to produce on their own immediately after birth. Its product line extension, Tri-Shield First Defense, is the first calf-level, passive antibody product providing Immediate Immunity against each of the three causes of calf scours (E. coli, coronavirus, and rotavirus).

Key people

Michael F. Brigham
President, Chief Executive Officer, Treasurer, Secretary, Director
Bobbi Jo Brockmann
Vice President - Sales and Marketing, Director
Elizabeth Luttrell Williams
Vice President - Manufacturing Operations
David Scott Tomsche
Independent Non-Executive Chairman of the Board
Gloria J. Basse
Independent Director
Bryan K. Gathagan
Independent Director
Steven T. Rosgen
Independent Director
Paul R. Wainman
Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US4525253062
  • Market cap
    $45.00m
  • Employees
    74
  • Shares in issue
    8.97m
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.